Diabetic Retinopathy Global Clinical Trials Review, H1, 2014 - NEWS10 ABC: Albany, New York News, Weather, Sports

Diabetic Retinopathy Global Clinical Trials Review, H1, 2014

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE ReportBuyer

LONDON, Aug. 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Diabetic Retinopathy Global Clinical Trials Review, H1, 2014

http://www.reportbuyer.com/pharma_healthcare/research_rd/clinical_trials/diabetic_retinopathy_global_clinical_trials_review.html

Diabetic Retinopathy Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, "Diabetic Retinopathy Global Clinical Trials Review, H1, 2014" provides data on the Diabetic Retinopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Retinopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Retinopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Introduction 6
Diabetic Retinopathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Diabetic Retinopathy to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Diabetic Retinopathy to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Diabetic Retinopathy 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Diabetic Retinopathy Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Diabetic Retinopathy 34
Jun 03, 2013: Oxford BioMedic Voluntarily Pauses Recruitment Into Phase I Study Of RetinoStat 34
May 07, 2012: Promedior Presents Preclinical Data Of Pentraxin-2 At ARVO Annual Meeting 34
May 01, 2012: Promedior To Present Data From Preclinical Studies Of Pentraxin-2 At ARVO Annual Meeting 35
May 01, 2012: Promedior To Present Preclinical Data Of Pentraxin-2 At ARVO Annual Meeting 35
Mar 19, 2012: Ampio Announces Positive Preliminary Update On Optina Clinical Trial To Treat Diabetic Macular Edema 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
Valeant Pharmaceuticals International, Inc. 40
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 40
Allergan, Inc. 41
Clinical Trial Overview of Allergan, Inc. 41
Takeda Pharmaceutical Company Limited 42
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 42
Eli Lilly and Company 43
Clinical Trial Overview of Eli Lilly and Company 43
AstraZeneca PLC 44
Clinical Trial Overview of AstraZeneca PLC 44
BCN Peptides, S.A. 45
Clinical Trial Overview of BCN Peptides, S.A. 45
Clinical Trial Overview of Top Institutes / Government 46
National Eye Institute 46
Clinical Trial Overview of National Eye Institute 46
University of Sao Paulo 47
Clinical Trial Overview of University of Sao Paulo 47
National Taiwan University Hospital 48
Clinical Trial Overview of National Taiwan University Hospital 48
Association for Innovation and Biomedical Research on Light and Image 49
Clinical Trial Overview of Association for Innovation and Biomedical Research on Light and Image 49
Medical University of Vienna 50
Clinical Trial Overview of Medical University of Vienna 50
Moorfields Eye Hospital NHS Foundation Trust 51
Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust 51
Diabetic Retinopathy Clinical Research Network 52
Clinical Trial Overview of Diabetic Retinopathy Clinical Research Network 52
Shahid Beheshti University of Medical Sciences 53
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 53
HOSPITAL JUAREZ DE MEXICO 54
Clinical Trial Overview of HOSPITAL JUAREZ DE MEXICO 54
Federal University of Sao Paulo 55
Clinical Trial Overview of Federal University of Sao Paulo 55
Five Key Clinical Profiles 56
Appendix 117
Abbreviations 117
Definitions 117
Research Methodology 118
Secondary Research 118
About GlobalData 119
Contact Us 119
Disclaimer 119
Source 119

List of Tables

Diabetic Retinopathy Therapeutics, Global, Clinical Trials by Region, 2014* 7
Diabetic Retinopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Diabetic Retinopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Diabetic Retinopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Diabetic Retinopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Diabetic Retinopathy Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Diabetic Retinopathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Diabetic Retinopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Diabetic Retinopathy to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Diabetic Retinopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Diabetic Retinopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Diabetic Retinopathy to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Diabetic Retinopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Diabetic Retinopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Diabetic Retinopathy Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Diabetic Retinopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Diabetic Retinopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Diabetic Retinopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Diabetic Retinopathy Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Diabetic Retinopathy Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Diabetic Retinopathy Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Diabetic Retinopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Diabetic Retinopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Diabetic Retinopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Diabetic Retinopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Diabetic Retinopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 37
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 39
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2014* 40
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014* 41
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 42
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 43
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 44
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by BCN Peptides, S.A., 2014* 45
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014* 46
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014* 47
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 48
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Association for Innovation and Biomedical Research on Light and Image, 2014* 49
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 50
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Moorfields Eye Hospital NHS Foundation Trust, 2014* 51
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Diabetic Retinopathy Clinical Research Network, 2014* 52
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2014* 53
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by HOSPITAL JUAREZ DE MEXICO, 2014* 54
Diabetic Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2014* 55

List of Figures

Diabetic Retinopathy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Diabetic Retinopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Diabetic Retinopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Diabetic Retinopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Diabetic Retinopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Diabetic Retinopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Diabetic Retinopathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Diabetic Retinopathy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Diabetic Retinopathy to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Diabetic Retinopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Diabetic Retinopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Diabetic Retinopathy to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Diabetic Retinopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Diabetic Retinopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Diabetic Retinopathy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Diabetic Retinopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Diabetic Retinopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Diabetic Retinopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Diabetic Retinopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Diabetic Retinopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Diabetic Retinopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Diabetic Retinopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Diabetic Retinopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 118


Read the full report:
Diabetic Retinopathy Global Clinical Trials Review, H1, 2014

http://www.reportbuyer.com/pharma_healthcare/research_rd/clinical_trials/diabetic_retinopathy_global_clinical_trials_review.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

341 Northern Blvd., Albany, NY 12204

Telephone: 518.436.4822
Fax: 518.426.4792
Email: news@news10.com

Can’t find something?
Powered by WorldNow
All content © Copyright 2000 - 2014 Young Broadcasting of Albany, Inc. A Media General Company.